Please login to the form below

Not currently logged in
Email:
Password:

Piramal sells clinical research arm to Indoco

Piramal Clinical Research sold for an undisclosed sum

Piramal 

Piramal Enterprises has signed a definitive agreement to sell its clinical research division to India-based manufacturing and marketing pharma firm Indoco Remedies.

The Hyderabad, India, based division Piramal Clinical Research, formerly known as Wellquest, specialises in conducting bioanalytical and bioequivalence studies for generic products and holds approvals from regulatory agencies including the FDA and NHRA.

Dr Swati Piramal, vice chairman of Piramal Enterprises, told PMLiVE: “The clinical trial facility was for bioequivalence studies mainly for generics. When we started it over a decade ago there were few if any facilities that had regulatory approval from regulated markets like UK or USFDA. That was important for export of generics. 

“Our core business has changed since 2010 with a focus on contract manufacturing and research. This facility was not part of the core strategy and the turnover is small so there will be a negligible impact on revenue.”

The facility is spread across 30,000 square feet and is equipped with a 98-bed facility, monitoring stations, phlebotomy stations, four-bed ICU, analytical lab and capabilities of eCTD submission.

Aditi Kare Panandikar, managing director of Indoco, commented: “We are extremely happy to have the CRO division of Piramal as part of Indoco. This acquisition will expand the depth of our services to customers in India as well as across the globe and would reduce our dependability to outsource bio-equivalence studies.

“Apart from reducing cost and ensuring time-bound outcome of studies, the CRO would be a perfect fit to our existing R&D efforts, including facilitation of ANDA/Dossier filings.”

The financial details of the deal have not been divulged.

Article by
Kirstie Pickering

10th April 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics